LogicBio Therapeutics Reports Full Year 2021 Financial Results and Provides Business Updates

/PRNewswire/ -- LogicBio® Therapeutics, Inc. (Nasdaq: LOGC), a clinical-stage genetic medicine company, today reported financial results for the year ended...

Related Keywords

United States ,Susanr Kahn ,Adam Daley ,Stephen Jasper ,Frederic Chereau ,Daiichi Sankyo Company ,European Society Of Gene ,Drug Administration ,Logicbio Therapeutics Inc ,Takeda Pharmaceutical Company ,Nasdaq ,Exchange Commission ,National Tay Sachs Allied Diseases Association ,Canbridge Care Pharma Hong Kong ,Therapeutics Inc ,Gilmartin Group ,Berry Company Public Relations ,European Medicines Agency ,Cell Therapy Virtual Congress ,Business Updates ,Investigational New Drug Application ,Data Safety Monitoring Board ,National Tay Sachs ,Allied Diseases Association ,European Society ,Care Pharma Hong Kong Limited ,Bio Therapeutics ,Methylmalonic Acidemia ,Hereditary Tyrosinemia Type ,Private Securities Litigation Reform Act ,Quarterly Report ,Ended December ,Logicbio Therapeutics ,Health Care Amp Hospitals ,Biotechnology ,Earnings ,